Fusion Antibodies

About:

Fusion Antibodies specializes in producing humanized monoclonal antibodies and antibody engineering projects.

Website: http://www.fusionantibodies.com

Twitter/X: fsnantibodies

Top Investors: Clarendon Fund Managers, Invest Northern Ireland, QUBIS, Crescent Capital, University Challenge Fund

Description:

Fusion Antibodies specializes in production of high quality humanized monoclonal antibodies and antibody engineering projects. The company has the knowledge and expertise to build and deliver a bespoke package of the services people need to achieve outstanding results. Using the technology, the sequences of the antibody variable domains which determine its binding specificity are incorporated into human donor sequences creating a panel of full length humanized antibodies for expression. Fully humanized monoclonal antibodies are an essential step in the progression of your drug to the clinic and the in-house expertise at Fusion Antibodies ensures its success. All of Fusion Antibodies services are offered on a fee-for-service basis and is flexible on the elements of the project people would like included. Fusion Antibodies have strong links with the several partners around the globe, allowing it to deliver a complete bespoke package, at an incredible price. Fusion Antibodies was founded on 2001 and is based in Belfast, United Kingdom.